Jun 9, 2023 12:07PM
Jun 9, 2023 12:05PM
Apr 14, 2023 12:05PM
Oct 21, 2022 09:00PM
Oct 16, 2022 11:24PM
Oct 11, 2022 10:05PM
Oct 6, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
Oct 2, 2022 09:00PM
Sep 26, 2022 09:00PM
Sep 21, 2022 09:00PM
Sep 16, 2022 09:00PM
Sep 12, 2022 06:57AM
Sep 12, 2022 06:55AM
Sep 11, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm
Sep 6, 2022 10:17PM
Aug 10, 2022 04:50PM
Jul 6, 2022 08:08AM
Jul 6, 2022 08:00AM
Jul 6, 2022 08:00AM
May 5, 2022 04:00PM
Feb 28, 2022 01:05PM Humanigen Reports Year-End 2021 Financial Results
Jan 10, 2022 08:40AM
Jan 10, 2022 05:58AM
Jan 10, 2022 05:55AM
Jan 5, 2022 06:05AM
Jan 4, 2022 05:55AM
Nov 12, 2021 04:00PM
Oct 8, 2021 02:00AM Humanigen Signs Contract With Clinigen for Lenzilumab Managed Access Program in Europe
Sep 10, 2021 10:19AM
Sep 9, 2021 07:26AM
Sep 9, 2021 06:12AM
Sep 9, 2021 12:40AM
Sep 9, 2021 12:16AM
Aug 12, 2021 04:00PM
Aug 4, 2021 06:11AM Humanigen Inc. (HGEN) Says Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
Aug 4, 2021 06:00AM
Jul 30, 2021 11:07AM
Jul 30, 2021 11:06AM
Jul 22, 2021 09:59AM
Jul 9, 2021 08:14AM
Jun 14, 2021 06:30AM
Jun 14, 2021 06:30AM Humanigen Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)
Jun 3, 2021 08:00AM
May 28, 2021 09:03AM
May 28, 2021 09:00AM
May 19, 2021 07:00AM
May 13, 2021 04:01PM
Apr 19, 2021 07:02AM
Apr 19, 2021 07:00AM Humanigen Reports Positive Data With Lenzilumab in the ZUMA-19 CAR-T Phase 1b Study in DLBCL and Plans to Initiate a Potential Registrational Study
Apr 6, 2021 02:02PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All